Stryker closes acquisition of Cerus Endovascular

▤ Summary

Cerus Endovascular is involved in the design, development, manufacture and supply of interventional neurovascular devices and delivery systems used by neuroradiologists for the treatment of intracranial aneurysms. The company’s offerings include the Contour Neurovascular System and the Neqstent Coil Assisted Flow Diverter. Together, we will enable physicians to treat a broader range of aneurysms.” Stryker’s Neurovascular division is focused on technology for the endovascular treatment of aneurysms. The addition of Cerus Endovascular’s portfolio is expected to accommodate the increasing demand for one-and-done intrasaccular aneurysm therapy. Global law firm Dechert was appointed by Cerus Endovascular to advise on the deal with Stryker.

▦ Linked Companies